『Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases』のカバーアート

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

 In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies. Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future. Related content: https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272

https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseasesに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。